Table 5.
The 10 Most Frequent AEs (Safety Population)
| Lumiracoxib 100 mg o.d. (n = 755) | Lumiracoxib 100 mg b.i.d. (n = 1,519) | Celecoxib 200 mg o.d. (n = 758) | |
| Headache | 82 (10.9) | 174 (11.5) | 82 (10.8) |
| Nasopharyngitis | 80 (10.6) | 141 (9.3) | 75 (9.9) |
| Back pain | 46 (6.1) | 87 (5.7) | 52 (6.9) |
| Arthralgia | 53 (7.0) | 82 (5.4) | 41 (5.4) |
| Abdominal pain upper | 42 (5.6) | 88 (5.8) | 35 (4.6) |
| Upper respiratory tract infection | 36 (4.8) | 86 (5.7) | 43 (5.7) |
| Dyspepsia | 38 (5.0) | 85 (5.6) | 39 (5.1) |
| Urinary tract infection | 38 (5.0) | 75 (4.9) | 24 (3.2) |
| Sinusitis | 21 (2.8) | 58 (3.8) | 34 (4.5) |
| Influenza | 30 (4.0) | 53 (3.5) | 28 (3.7) |
o.d. = once daily; b.i.d. = twice daily.